CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,817 | -21.2% | 40,023 | -2.5% | 0.00% | -20.0% |
Q2 2023 | $2,305 | +26.4% | 41,061 | +1.8% | 0.01% | +25.0% |
Q1 2023 | $1,824 | -12.1% | 40,341 | -21.0% | 0.00% | -20.0% |
Q4 2022 | $2,076 | -100.0% | 51,084 | -52.4% | 0.01% | -72.2% |
Q3 2022 | $7,013,000 | +148.2% | 107,328 | +130.8% | 0.02% | +157.1% |
Q2 2022 | $2,825,000 | +4.4% | 46,498 | +7.8% | 0.01% | +16.7% |
Q1 2022 | $2,706,000 | +0.9% | 43,114 | +21.8% | 0.01% | 0.0% |
Q4 2021 | $2,681,000 | -37.6% | 35,383 | -7.8% | 0.01% | -45.5% |
Q3 2021 | $4,297,000 | -24.2% | 38,393 | +9.6% | 0.01% | -21.4% |
Q2 2021 | $5,668,000 | +54.4% | 35,015 | +16.2% | 0.01% | +40.0% |
Q1 2021 | $3,672,000 | -13.9% | 30,140 | +8.2% | 0.01% | -23.1% |
Q4 2020 | $4,266,000 | +106.4% | 27,865 | +12.7% | 0.01% | +85.7% |
Q3 2020 | $2,067,000 | +12.6% | 24,718 | -1.0% | 0.01% | 0.0% |
Q2 2020 | $1,835,000 | -1.7% | 24,975 | -43.3% | 0.01% | -22.2% |
Q1 2020 | $1,867,000 | +0.4% | 44,039 | +44.2% | 0.01% | +28.6% |
Q4 2019 | $1,859,000 | +149.2% | 30,532 | +67.7% | 0.01% | +133.3% |
Q3 2019 | $746,000 | -11.1% | 18,201 | +2.2% | 0.00% | -25.0% |
Q2 2019 | $839,000 | +39.6% | 17,815 | +5.9% | 0.00% | +33.3% |
Q1 2019 | $601,000 | +65.1% | 16,829 | +32.1% | 0.00% | +50.0% |
Q4 2018 | $364,000 | -38.3% | 12,741 | -4.3% | 0.00% | -33.3% |
Q3 2018 | $590,000 | -18.8% | 13,318 | +7.6% | 0.00% | -25.0% |
Q2 2018 | $727,000 | +176.4% | 12,373 | +114.3% | 0.00% | +300.0% |
Q1 2018 | $263,000 | – | 5,773 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |